USPTO serial 79310658
CELLCITY
Reviewed by CopyMark Law Group
Reg. 7088741Status 404
- Filing date
- Status date
- Registration date
- Jun 27, 2023
- Examiner
- LAM, HAI-LY HUYNH
- Law office
- TMO LAW OFFICE 119
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CELLCITY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Leigh Ann Lindquist
Leigh Ann Lindquist SUGHRUE MION, PLLC2000 Pennsylvania Avenue NW, Suite 9000Washington, DC 20006UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological, chemical, biochemical and biotechnological products for industrial and scientific purposes, in particular nucleic acids, enzymes, polymerases, fluorescent dyes and molecular labels, molecular probes being biochemical reagents, buffers, aqueous and non-aqueous solutions of alcohols and/or salts, distilled or purified water, silicates, magnetic nanoparticles, and column materials in the nature of chromatography chemicals; reagents and solvents for scientific and industrial purposes, namely, nucleic acids, enzymes, proteins, macromolecules and biologically active substances, for sample preparation, purification, lysis, modification and/or manipulation of cells as well as for performing labeling, separation, isolation, purification, amplification and/or analysis methods for biopolymers; kits for laboratory or research use containing biological, chemical, biochemical and/or biotechnological products, namely, nucleic acids, enzymes, proteins, macromolecules and biologically active substances, in particular nucleic acids from biological or biochemical sample material, for sample preparation, purification, lysis, modification and manipulation of cells as well as for performing labeling, separation, isolation, purification, amplification and/or analysis methods for biopolymers | SECTION 70 - CANCELLED | — |
| 005 | Diagnostic preparations for medical and veterinary purposes, in particular for the diagnosis of infectious diseases, tumor diseases, allergies, autoimmune diseases, cardiovascular diseases and metabolic diseases; products for human medical and/or veterinary purposes, namely, diagnostic preparations for medical and veterinary purposes, enzymes, cells, cultures of micro-organisms and cultures of cells; diagnostic preparations for medical and/or veterinary purposes, namely, nucleic acids, enzymes, polymerases, fluorescent dyes and molecular labels, molecular probes being biochemical reagents, buffers, aqueous and non-aqueous solutions of alcohols and/or salts, distilled or purified water, silicates, magnetic nanoparticles, column materials in the nature of chromatography chemicals, biological, chemical, biochemical and biotechnological preparations; kits for medical diagnostic or veterinary diagnostic purposes, containing diagnostic biological, chemical, biochemical and/or biotechnological agents, preparations and substances, namely, nucleic acids, enzymes, proteins, macromolecules and biologically active substances used for sample preparation, purification, lysis, modification and/or manipulation of cells as well as for labeling, separation, isolation, purification, amplification and/or analysis of biopolymers, all for use in disease detection | SECTION 70 - CANCELLED | — |
| 009 | Scientific apparatus, instruments and devices, namely, microfluidic systems for bio-sensing and diagnostic purposes consisting of microfluidic chips, biochips, cell culture chips, microchips, biosensors, micropumps, micromixers, microfilters, microseparators, microconcentrators, micro droplet devices and microtraps for hydrodynamic trapping of particles; scientific apparatus, instruments and devices, namely, cell culture plates, cell culture chips, microfluidic chips for cells, biochips, nanoliter dispensing pumps, vacuum pumps for laboratory use, chromatography columns, laboratory robots and spare parts and equipment therefor, in particular, pre-recorded flash memory and USB cards featuring automation of detection, testing, measurement and analysis methods in laboratories, microplates, pipettes, pipette tips, pipette tip holders, test vessels, reagent holders, flasks, test tube holders, holders for microvessels, magnetic syringes, biochips, thermocyclers, homogenizers, and vacuum valves, all for scientific or laboratory use; scientific apparatus, instruments and devices, in particular electronic control units for controlling the aforementioned microfluidic systems; incubators and temperature chambers all for laboratory purposes; laboratory systems comprising electronic control units and incubators or temperature chambers as well as microfluidic systems consisting of microfluidic chips, biochips, cell culture chips, microchips, biosensors, micropumps, micromixers, microfilters, microseparators, microconcentrators and micro droplet devices; all the foregoing goods, in particular for scientific and laboratory research, development and investigation purposes, namely, for sample preparation, modification and manipulation of cells, and for labeling, separation, isolation, purification, amplification and/or analysis of biopolymers being nucleic acids, proteins, macromolecules and biologically active substances being proteins and/or nucleic acids from biological or biochemical sample material; measuring apparatuses and instruments for food diagnostics, namely, diagnostic apparatus for detection of microorganisms, heavy metals, allergens, additives, biotoxins, pesticides residues, chemical substances and nutritional values in different food samples | SECTION 70 - CANCELLED | — |
| 010 | Devices for medical and veterinary purposes, namely, instruments for medical or veterinary diagnostic purposes, in particular for the diagnosis of infectious diseases, tumor diseases, allergies, autoimmune diseases, cardiovascular diseases and metabolic diseases; diagnostic, examination and monitoring devices for medical and veterinary purposes, in particular cell culture chambers for medical and veterinary purposes; artificial organs, namely, artificial hearts, artificial livers, artificial kidneys, artificial spleens, artificial thyroids, artificial dermal tissue, artificial subcutaneous tissue, artificial digestive organs, and implants consisting of artificial materials and of artificial tissue | SECTION 70 - CANCELLED | — |
| 042 | Scientific and technological services, namely, scientific research and development and product research and development in the field of laboratory diagnostics, chemistry, genetics, biology, biotechnology and biochemistry; laboratory analysis and research in the field of DNA, RNA and protein detection and analysis for use in * medical diagnostics, namely, * diagnosing infectious diseases, tumor diseases, allergies, autoimmune diseases, cardiovascular diseases and metabolic diseases | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by EVORION Biotechnologies GmbH
- Other trademarks owned by EVORION Biotechnologies GmbH
- Other trademarks owned by EVORION Biotechnologies GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named CELLCITY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 19, 2026 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jan 20, 2026 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jan 20, 2026 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Nov 30, 2025 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Nov 30, 2025 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jul 10, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 22, 2024 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Jan 16, 2024 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Jan 16, 2024 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Jan 7, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 14, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 14, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 14, 2023 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Dec 14, 2023 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Sep 27, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 27, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 27, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 16, 2023 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| May 17, 2023 | ISMR | WITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST | — |
| May 16, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 16, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 16, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 26, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 26, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 26, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 12, 2023 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Mar 1, 2023 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jan 31, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 31, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 31, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 11, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 11, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 11, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 29, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 30, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 30, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 30, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 30, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 7, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 4, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 4, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 4, 2022 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 19, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 19, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 24, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 24, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 24, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 9, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 9, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 6, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 6, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 6, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 30, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 7, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 7, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 24, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 23, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 17, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 21, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 17, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 13, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |